Latest filing published 23 May 2025 for Privia Health Group, Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +1.4%Entry US$41.61 · Close at T+365 US$42.20
- +21.3%Entry US$238.05 · Close at T+365 US$288.77
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
David S. Wichmann: trading record in brief
David S. Wichmann's purchases and sales split evenly: two of each, so purchases are 50% of the open-market trades. The purchases weigh EUR 5,066,121 in total: EUR 4,148,902 at Unitedhealth Group Inc on May 3, 2019 and EUR 917,219 at Boston Scientific Corp on November 15, 2021. The two sales, at Tennant Co, are EUR 103,168 on August 16, 2019 and EUR 97,697 on December 3, 2020, EUR 200,865 altogether.
The record counts 99 filings published between February 9, 2016 and May 23, 2025: Unitedhealth Group Inc (79, as Chief Executive Officer), Tennant Co (10), Boston Scientific Corp (7) and Privia Health Group, Inc. (3), the last three as Director. The flow is dominated by 85 share grants, with 9 option exercises and one filing of another kind.
Activity concentrates in 2016 to 2020: 13, 22, 14, 20 and 20 filings, then 1 or 2 a year, except 3 in 2023. Publication median: 2 days. No filing in the last twelve months.
The count of trades by Wichmann within 30 days of colleagues at Tennant Co is 2, 2 and 1. All in the same direction. The colleagues, in the same order: Chris Killingstad, Richard H. Zay and Carol S. Eicher.
Companies and markets linked to David S. Wichmann
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,396 shares0Common Stock, par value $0.01 per shareSEC:0001759655-25-000075:0
- 2,081 shares0Common StockSEC:0001225208-25-004935:0
- 11,124 shares0Common Stock, par value $0.01 per shareSEC:0001759655-24-000087:0
- 2,901 shares0Common StockSEC:0001225208-24-005972:0
- 6,189 shares0Common Stock, par value $0.01 per shareSEC:0001268489-23-000010:0
- 3,946 shares0Common StockSEC:0001225208-23-005471:0
- 41 shares0Common StockSEC:0001225208-23-004618:0
- 2,736 shares0Common StockSEC:0001225208-22-006634:1
- 4,877 shares0Common StockSEC:0001225208-22-006634:0
- 25,000 shares@ US$41.978100.0% of flowCommon StockSEC:0001225208-21-013899:0Canonical exit: 13 Feb 2022 (T+90)
- 113.465 shares0Common StockSEC:0001209191-20-064149:0
- 465.336 shares@ US$339.340.6% of flowCommon StockSEC:0001209191-20-064149:1
- 1,750 shares@ US$40.8137.6% of flowCommon StockSEC:0001179110-20-011725:0
- 1,750 shares@ US$67.632262.4% of flowCommon StockSEC:0001179110-20-011725:1
- 130.42 shares0Common StockSEC:0001209191-20-051936:0
- 597 shares@ US$323.700.7% of flowCommon StockSEC:0001209191-20-046943:0
- 134.94 shares0Common StockSEC:0001209191-20-040480:0
- 1,955 shares0Common StockSEC:0001179110-20-005928:0
- 155.69 shares0Common StockSEC:0001209191-20-021275:0
- 1,199 shares@ US$263.001.3% of flowCommon StockSEC:0001209191-20-014098:0
- 1,478 shares@ US$302.201.8% of flowCommon StockSEC:0001209191-20-010124:0
- 17,400 shares@ US$302.2021.7% of flowCommon StockSEC:0001209191-20-010124:2
- 7,422 shares@ US$302.209.2% of flowCommon StockSEC:0001209191-20-010124:4
- 35,365 shares0Common StockSEC:0001209191-20-010124:1
- 15,084 shares0Common StockSEC:0001209191-20-010124:3
25 of 178 declarations
